Azitra is trading 5.8% down today at $0.14, giving back a portion of its recent speculative gains as the broader biotechnology sector faces selling pressure.
- The move appears tied to typical low-float micro-cap volatility, with no new company-specific news or regulatory filings reported today.
- The broader biotech sector has declined 2%, reflecting a risk-off tone in smaller-cap names despite major market indices trading in positive territory.